Pdt Partners, LLC Edwards Lifesciences Corp Transaction History

Pdt Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $1.24 Million - $1.67 Million	17,896 New	17,896 $1.24 Million
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $2,868 - $3,672	-42 Reduced 0.46%	8,994 $671,000
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $1.38 Million - $1.79 Million	-16,697 Reduced 64.89%	9,036 $747,000
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $2.23 Million - $3.3 Million	25,733 New	25,733 $2.45 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.